A privacy-preserving, ethically governed blockchain–digital twin framework for auditable molecular comparison and biocomponent provenance recording
Frontiers in Bioengineering and Biotechnology · 04.11.2026 · 14
DOI: 10.3389/fbioe.2026.1960726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 04.11.2026. Verfasst von Muhammad Farooq Shaikh und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering, University of Warwick, Coventry, United Kingdom. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Convalescent plasma and other biocomponent transfusions offer rapidly deployable interventions against emerging infectious diseases. However, their use is constrained by adverse-reaction risks and the absence of a shared, tamper-evident record of previously compared donor compositions and associated outcomes.
Objective
To develop a privacy-preserving, ethically governed blockchain-digital twin proof-of-concept for auditable molecular comparison and biocomponent provenance recording.
Methods
Digital-twin representations of plasma, serum and related biocomponents were instantiated using chemical formulae, SMILES strings and sequence data retrieved from ChEMBL release 33 (2023). These representations were maintained in a relational working store connected to a permissioned, Ethereum-compatible Proof-of-Authority ledger. Smart contracts recorded finalised comparisons as immutable transactions following majority validation by three randomly selected validators.
Results
The framework integrated molecular representation, fingerprint-based similarity matching, best-match selection and ledger-based provenance recording. Ten equations formalised twin representation, similarity matching, best-match selection, majority-consensus validation, validator-collusion probability, spam deterrence, gas cost, throughput, latency and storage overhead.
Conclusion
This proof-of-concept provides a formal foundation for auditable molecular comparison and traceable biocomponent records. Molecular similarity alone does not establish transfusion compatibility or clinical safety; experimental and clinical validation remain necessary before clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Engineering, University of Warwick, Coventry, United Kingdom.
- Department of Computer Science, National University of Computer and Emerging Sciences, Islamabad, Pakistan.
- Department of Electrical and Computer Engineering, School of Engineering, University of Patras, Patras, Greece.
Zitieren
APA
Shaikh, M. F., Sherwani, F., Matevosyan, S., & Piaggio, D. (2026). A privacy-preserving, ethically governed blockchain–digital twin framework for auditable molecular comparison and biocomponent provenance recording. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1960726
Vancouver
Shaikh MF, Sherwani F, Matevosyan S, Piaggio D. A privacy-preserving, ethically governed blockchain–digital twin framework for auditable molecular comparison and biocomponent provenance recording. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1960726
BibTeX
@article{Shaikh2026,
author = {Shaikh, Muhammad Farooq and Sherwani, Fahad and Matevosyan, Syuzanna and Piaggio, Davide},
title = {A privacy-preserving, ethically governed blockchain–digital twin framework for auditable molecular comparison and biocomponent provenance recording},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1960726}
}
EUVIMED